Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

BEAT-IT: Comparing a behavioural activation treatment for depression in adults with intellectual disabilities with an attention control: study protocol for a randomised controlled trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: [London] : BioMed Central, 2006-
    • الموضوع:
      Attention*; Behavior Therapy/*methods ; Depression/*therapy ; Intellectual Disability/*psychology ; Persons with Mental Disabilities/*psychology; Adult ; Behavior Therapy/economics ; Clinical Protocols ; Cost-Benefit Analysis ; Depression/diagnosis ; Depression/economics ; Depression/psychology ; Health Care Costs ; Humans ; Intellectual Disability/diagnosis ; Psychiatric Status Rating Scales ; Research Design ; Single-Blind Method ; Time Factors ; Treatment Outcome ; United Kingdom
    • نبذة مختصرة :
      Background: Depression appears to be more enduring amongst people with intellectual disabilities, suggesting that it is a more chronic problem or more poorly managed in this population. This is not helped by a lack of evidence about the effectiveness of psychological therapies for people who have intellectual disabilities and depression. Behavioural activation, which aims to counteract depression by increasing individuals' level of meaningful activity and their exposure to positive reinforcers, has proven to be as effective as cognitive behavioural therapy in the general population. Given that this therapy makes fewer communicative demands and focuses on activity, it was thought that behavioural activation would be both accessible and apt for people with intellectual disabilities, who are often socially marginalised.
      Methods/design: This study is a multi-centre single-blind randomised controlled trial of behavioural activation versus a self-help attention control intervention for depression in adults with mild/moderate intellectual disabilities. The study has an internal pilot in one centre, to establish that recruitment can be built up and sustained at the required level, before being rolled out across the other sites. One hundred sixty-six participants will be randomly assigned to the behavioural activation or self-help interventions, which will be delivered to individuals with mild to moderate intellectual disabilities, accompanied by someone who provides them with regular support. Both interventions are manualised and will be delivered over a period of approximately 4 months. The primary outcome measure will be the Glasgow Depression Scale, a self-report measure which is completed at baseline and 4 and 12 months post-randomisation. Secondary outcomes include measures of participants' activity levels, proxy reports of depressive symptoms, and cost-effectiveness.
      Discussion: The study will provide evidence about the effectiveness of behavioural activation for depression, adapted for people who have mild/moderate intellectual disabilities, and will inform the delivery of psychological therapies to people with intellectual disabilities in practice.
      Trial Registration: Date trial registered: Nov. 13, 2012; trial registration number: ISRCTN 09753005.
    • References:
      Behav Modif. 2001 Apr;25(2):255-86. (PMID: 11317637)
      J Intellect Disabil Res. 2015 Nov;59(11):1010-21. (PMID: 25496397)
      J Intellect Disabil Res. 2003 Jan;47(Pt 1):22-30. (PMID: 12558692)
      Br J Psychiatry Suppl. 2000;(39):s28-33. (PMID: 10945075)
      Psychiatry Res. 1986 Mar;17(3):203-12. (PMID: 3704028)
      J Intellect Disabil Res. 2009 Sep;53(9):759-71. (PMID: 19627425)
      Health Econ. 2005 May;14(5):487-96. (PMID: 15497198)
      Res Dev Disabil. 2013 Nov;34(11):4210-21. (PMID: 24077070)
      J Consult Clin Psychol. 2006 Aug;74(4):658-70. (PMID: 16881773)
      Br J Psychiatry. 2007 Jan;190:27-35. (PMID: 17197653)
      J Intellect Disabil Res. 2007 Mar;51(Pt 3):207-17. (PMID: 17300416)
      Psychol Med. 2007 Jun;37(6):873-82. (PMID: 17274854)
      Qual Life Res. 2010 Aug;19(6):875-86. (PMID: 20405245)
      Am J Ment Retard. 2002 May;107(3):222-32. (PMID: 11966335)
      Contemp Clin Trials. 2011 Sep;32(5):641-8. (PMID: 21570485)
      Br J Psychiatry. 2004 Oct;185:350-1. (PMID: 15458996)
      Br J Psychiatry. 2003 Apr;182:347-53. (PMID: 12668412)
      Trials. 2011 Apr 14;12:95. (PMID: 21492437)
      Int Rev Psychiatry. 2011 Aug;23(4):318-27. (PMID: 22026487)
      Br J Psychiatry. 2000 Nov;177:452-6. (PMID: 11060000)
      J Intellect Disabil Res. 2002 Feb;46(Pt 2):144-50. (PMID: 11869385)
      J Gerontol A Biol Sci Med Sci. 2002 Jul;57(7):M470-2. (PMID: 12084811)
      Res Dev Disabil. 2013 Nov;34(11):4085-102. (PMID: 24051363)
      J Intellect Disabil Res. 2003 Sep;47 Suppl 1:3-15. (PMID: 14516368)
      Psychol Med. 2008 May;38(5):611-23. (PMID: 17903337)
      J Autism Dev Disord. 2001 Dec;31(6):577-88. (PMID: 11814269)
    • Grant Information:
      10/104/34 United Kingdom DH_ Department of Health
    • Molecular Sequence:
      ISRCTN ISRCTN09753005
    • الموضوع:
      Date Created: 20151231 Date Completed: 20160907 Latest Revision: 20240523
    • الموضوع:
      20240523
    • الرقم المعرف:
      PMC4696180
    • الرقم المعرف:
      10.1186/s13063-015-1103-5
    • الرقم المعرف:
      26714891